Literature DB >> 9094671

Low-frequency loss of heterozygosity in Moloney murine leukemia virus-induced tumors in BRAKF1/J mice.

J K Lander1, H Fan.   

Abstract

To identify potential involvement of tumor suppressor gene inactivation during leukemogenesis by Moloney murine leukemia virus (M-MuLV), a genome-wide scan for loss of heterozygosity (LOH) in tumor DNAs was made. To assess LOH, it is best to study mice that are heterozygous at many loci across the genome. Accordingly, we generated a collection of 52 M-MULV-induced tumor DNAs from C57BR/cdJ x AKR/J F1 (BRAKF1) hybrid mice. By using direct hybridization with oligonucleotides specific for three different classes of endogenous MuLV-related proviruses, 48 markers on 16 of 19 autosomes were simultaneously examined for allelic loss. No allelic losses were detected, with the exception of a common loss of markers on chromosome 4 in two tumors. The three autosomes that lacked informative endogenous proviral markers were also analyzed for LOH by PCR with simple-sequence length polymorphisms (SSLPs); one additional tumor showed LOH on chromosome 15. Further screening with chromosome 4 SSLPs identified one additional tumor with LOH on chromosome 4. Therefore, in total, the average fractional allelic loss was quite low (0.002), but the LOH frequency of 6% on chromosome 4 was highly statistically significant (P < 0.0005). Detailed SSLP mapping of the three tumors with LOH on chromosome 4 localized the region of common LOH to the distal 45 centimorgans, a region syntenic with human chromosomes 1 and 9. Candidate tumor suppressor genes, Mts1 (p16INK4a) and Mts2 (p15INK4b), have been mapped to this region, but by Southern blot analysis, no homozygous deletions were detected in either gene. One of three tumors with LOH on chromosome 4 also showed a proviral insertion near the c-myc proto-oncogene. These results suggested that tumor suppressor inactivation is generally infrequent in M-MuLV-induced tumors but that a subset of these tumors may have lost a tumor suppressor gene on chromosome 4.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094671      PMCID: PMC191546     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  85 in total

1.  Analysis of loss of heterozygosity in murine hepatocellular tumors.

Authors:  G Manenti; L De Gregorio; M Gariboldi; T A Dragani; M A Pierotti
Journal:  Mol Carcinog       Date:  1995-07       Impact factor: 4.784

2.  Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.

Authors:  M Gonzalez-Zulueta; C M Bender; A S Yang; T Nguyen; R W Beart; J M Van Tornout; P A Jones
Journal:  Cancer Res       Date:  1995-10-15       Impact factor: 12.701

3.  Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias.

Authors:  J Hebert; J M Cayuela; J Berkeley; F Sigaux
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

4.  Genome-wide search for loss of heterozygosity in transgenic mouse tumors reveals candidate tumor suppressor genes on chromosomes 9 and 16.

Authors:  W F Dietrich; E H Radany; J S Smith; J M Bishop; D Hanahan; E S Lander
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

5.  Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels.

Authors:  D A Largaespada; J D Shaughnessy; N A Jenkins; N G Copeland
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

6.  Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood.

Authors:  S Takeuchi; C R Bartram; T Seriu; C W Miller; A Tobler; J W Janssen; A Reiter; W D Ludwig; M Zimmermann; J Schwaller
Journal:  Blood       Date:  1995-07-15       Impact factor: 22.113

Review 7.  p53 and human cancers.

Authors:  D P Lane
Journal:  Br Med Bull       Date:  1994-07       Impact factor: 4.291

8.  Cloning and characterization of murine p16INK4a and p15INK4b genes.

Authors:  D E Quelle; R A Ashmun; G J Hannon; P A Rehberger; D Trono; K H Richter; C Walker; D Beach; C J Sherr; M Serrano
Journal:  Oncogene       Date:  1995-08-17       Impact factor: 9.867

9.  Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation.

Authors:  M E Hegi; T R Devereux; W F Dietrich; C J Cochran; E S Lander; J F Foley; R R Maronpot; M W Anderson; R W Wiseman
Journal:  Cancer Res       Date:  1994-12-01       Impact factor: 12.701

10.  Involvement of CDKN2 (p16INK4A/MTS1) and p15INK4B/MTS2 in human leukemias and lymphomas.

Authors:  T Otsuki; H M Clark; A Wellmann; E S Jaffe; M Raffeld
Journal:  Cancer Res       Date:  1995-04-01       Impact factor: 12.701

View more
  4 in total

1.  Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.

Authors:  E W Baxter; K Blyth; E R Cameron; J C Neil
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Loss of heterozygosity at the Ink4a/Arf locus facilitates Abelson virus transformation of pre-B cells.

Authors:  J Mostecki; A Halgren; A Radfar; Z Sachs; J Ravitz; K C Thome; N Rosenberg
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

3.  DNA bridging of yeast chromosomes VIII leads to near-reciprocal translocation and loss of heterozygosity with minor cellular defects.

Authors:  Valentina Tosato; Claudio Nicolini; Carlo V Bruschi
Journal:  Chromosoma       Date:  2008-11-18       Impact factor: 4.316

4.  Insertional mutagenesis and deep profiling reveals gene hierarchies and a Myc/p53-dependent bottleneck in lymphomagenesis.

Authors:  Camille A Huser; Kathryn L Gilroy; Jeroen de Ridder; Anna Kilbey; Gillian Borland; Nancy Mackay; Alma Jenkins; Margaret Bell; Pawel Herzyk; Louise van der Weyden; David J Adams; Alistair G Rust; Ewan Cameron; James C Neil
Journal:  PLoS Genet       Date:  2014-02-27       Impact factor: 5.917

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.